ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
-12.41%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$684M
AUM Growth
+$684M
(-6.2%)
Cap. Flow
+$23.4M
Cap. Flow
% of AUM
3.42%
Top 10 Holdings %
Top 10 Hldgs %
63.17%
Holding
29
New
6
Increased
11
Reduced
6
Closed
5
Top Buys
| 1 |
DexCom
DXCM
|
$38.8M |
| 2 |
Elanco Animal Health
ELAN
|
$38.4M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$33.5M |
| 4 |
McKesson
MCK
|
$30.4M |
| 5 |
Legend Biotech
LEGN
|
$30.4M |
Top Sells
| 1 |
Icon
ICLR
|
$54.2M |
| 2 |
AbbVie
ABBV
|
$29.8M |
| 3 |
Cooper Companies
COO
|
$28.8M |
| 4 |
Surgery Partners
SGRY
|
$26.1M |
| 5 |
Boston Scientific
BSX
|
$23.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Universal Health Services
UHS
$11.6B
| $63.1M | 9.22% | 501,800 +31,800 | +7% | +$4M |
|
2
Acadia Healthcare
ACHC
$2.12B
| $53.8M | 7.86% | 765,204 +261,757 | +52% | +$18.4M |
|
|
3
DexCom
DXCM
$29.5B
| $52.8M | 7.71% | 565,753 +415,753 | +277% | +$38.8M |
|
4
United Therapeutics
UTHR
$13.8B
| $47.6M | 6.95% | 210,635 +10,635 | +5% | +$2.4M |
|
5
Intuitive Surgical
ISRG
$170B
| $41.5M | 6.07% | 142,000 +22,000 | +18% | +$6.43M |
|
|
6
Elanco Animal Health
ELAN
$9.12B
| $38.4M | 5.61% | +3,412,350 | New | +$38.4M |
|
|
7
AbbVie
ABBV
$372B
| $37.3M | 5.45% | 250,000 -200,000 | -44% | -$29.8M |
|
|
8
Apellis Pharmaceuticals
APLS
$3.48B
| $33.5M | 4.89% | +880,000 | New | +$33.5M |
|
9
Glaukos
GKOS
$5.5B
| $32.4M | 4.73% | 430,000 +120,000 | +39% | +$9.03M |
|
|
10
Icon
ICLR
$13.8B
| $32M | 4.68% | 130,000 -220,000 | -63% | -$54.2M |
|
|
11
McKesson
MCK
$85.4B
| $30.4M | 4.45% | +70,000 | New | +$30.4M |
|
|
12
Legend Biotech
LEGN
$6.41B
| $30.4M | 4.44% | +452,629 | New | +$30.4M |
|
13
Establishment Labs
ESTA
$1.2B
| $28M | 4.09% | 570,126 +32,220 | +6% | +$1.58M |
|
14
10x Genomics
TXG
$1.74B
| $27.5M | 4.02% | 666,945 +286,945 | +76% | +$11.8M |
|
15
Bruker
BRKR
$5.16B
| $26.8M | 3.92% | +430,843 | New | +$26.8M |
|
|
16
Boston Scientific
BSX
$156B
| $21.1M | 3.09% | 400,000 -450,000 | -53% | -$23.8M |
|
17
Brookdale Senior Living
BKD
$1.83B
| $17.5M | 2.56% | 4,236,128 +52,775 | +1% | +$218K |
|
|
ITCI
18
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $17.2M | 2.52% | +330,549 | New | +$17.2M |
|
19
Exact Sciences
EXAS
$8.98B
| $17.1M | 2.49% | 250,000 -250,000 | -50% | -$17.1M |
|
20
Pacific Biosciences
PACB
$393M
| $15M | 2.2% | 1,800,000 -600,000 | -25% | -$5.01M |
|
|
OLK
21
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $10.9M | 1.59% | 738,062 +423,267 | +134% | +$6.24M |
|
22
908 Devices
MASS
$226M
| $6.53M | 0.95% | 980,463 +80,463 | +9% | +$536K |
|
|
SWTX
23
DELISTED
SpringWorks Therapeutics
SWTX
| $3.47M | 0.51% | 150,211 -314,724 | -68% | -$7.28M |
|
24
Align Technology
ALGN
$10.3B
| – | – | -65,000 | Closed | -$23M |
|
|
25
Cooper Companies
COO
$13.4B
| – | – | -75,000 | Closed | -$28.8M |
|